Mr. Speaker, we know that Canadians will receive two million doses of flu vaccine made in the U.S.A. this year. The federal government as broker has so decided. The other vaccines will come from BioVac, which says it is dissatisfied with the agreement because it must lay off 26 people in addition to cancelling a major investment project.
My question is addressed to the Solicitor General. Can he tell us whether it is a new provision of his code of ethics that led his Minister of Public Works himself to send a draft letter in which BioVac should express its satisfaction to him with regard to his decision to separate into two parts the contract for supplying vaccines, and does the Solicitor General support such a procedure?